Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Merck finally reveals chemical structure of lead COX-2 inhibitor

Nov. 6, 1998

Hungarian research team presents new antithrombotic thioglycosides

Nov. 2, 1998

Tacrolimus may represent novel neurotrophic strategy for neurodegenerative disorders

Oct. 30, 1998

Kappa-opioid antagonist MR-2266 is also an antagonist of ORL1 receptors

Oct. 30, 1998

AChE inhibition does not contribute to the neuroprotective effects of anseculin in vivo

Oct. 29, 1998

Alpha2-adrenoceptor antagonists useful as adjuncts to L-DOPA in PD

Oct. 28, 1998

Melagatran in different vehicles compared in rat model of thrombosis

Oct. 28, 1998

Clinical, preclinical efficacy of Neovastat featured at recent congress

Oct. 27, 1998

Pharmacokinetic and therapeutic equivalence of Zelapar and Eldepryl

Oct. 27, 1998

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...